GGrantIndex
← Leaderboards

John Morrey

Utah State University

$13,853,562
Attributed
$13,853,562
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3M · FY201125
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,853,562 · 2

By mechanism

N01$13,853,562 · 2

Top collaborators

No co-investigators on record.

Most similar at Utah State University

Same institution · by research overlap

Others in their field

Top investigators on “Contracts

Research focus

ContractsInfectious Disease ModelAnimal ModelStandardizationEfficacy TestingLicensureAnimal Model DevelopmentMouse ModelEvaluationBasic ScienceVirusScreeningCoxsackie VirusesPathogenic VirusFlavivirusIn VivoCommunicable DiseasesTherapeutic EvaluationPathogens Of Pandemic PotentialTherapeutic DevelopmentHuman PoliovirusAntiviral AgentsBiodefenseAlphavirus

Grant awards (45)

Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential$38,550
N01 · FY2025 · AI · contact PI
Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential$38,550
N01 · FY2025 · AI · contact PI
Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential$38,550
N01 · FY2025 · AI · contact PI
Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential$38,550
N01 · FY2025 · AI · contact PI
Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential$38,550
N01 · FY2025 · AI · contact PI
Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential$402,300
N01 · FY2024 · AI · contact PI
Task A59: Mouse Model for Evaluating Antivirals Against Polio and Coxsackie Virus$124,025
N01 · FY2024 · AI · contact PI
Task A74: APP- High Throughput Evaluation of Therapeutics in Small Animal Models of Coronavirus Infection$39,750
N01 · FY2024 · AI · contact PI
Task A59: Mouse Model for Evaluating Antivirals against Polio and Coxsackie Virus$186,037
N01 · FY2023 · AI · contact PI
Task A74: APP-High Throughput Evaluation of Therapeutics in Small Animal Models of Coronavirus Infection$39,750
N01 · FY2023 · AI · contact PI
Task A74: APP-High Throughput Evaluation of Therapeutics in Small Animal Models of Coronavirus Infection$1,072,875
N01 · FY2022 · AI · contact PI
Task A71: Comprehensive in vivo screening of viral pathogens of pandemic potential$424,755
N01 · FY2022 · AI · contact PI
Task A59: Mouse Model for Evaluating Antivirals against Polio and Coxsackie Virus$188,011
N01 · FY2021 · AI · contact PI
Task A59: Mouse Model for Evaluating Antivirals against Polio and Coxsackie Virus$188,011
N01 · FY2021 · AI · contact PI
Task A11: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES$928,138
N01 · FY2020 · DA · contact PI
Task A14: Hamster Model for Human Adenovirus$471,140
N01 · FY2020 · AI · contact PI
Task A13: Rabbit and Mouse Models for Papillomavirus.$280,583
N01 · FY2020 · AI · contact PI
Task A17: Mouse Model of enteroviruses Polio and Coxsackie for Therapeutics$155,199
N01 · FY2020 · AI · contact PI
Task A11: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES$946,052
N01 · FY2019 · AI · contact PI
Task A30: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential$534,397
N01 · FY2019 · AI · contact PI
Task A14: Hamster Model for Human Adenovirus$471,140
N01 · FY2019 · AI · contact PI
Task A17: Mouse Model of enteroviruses Polio and Coxsackie for Therapeutics$313,593
N01 · FY2019 · DA · contact PI
Task A13: Rabbit and Mouse Models for Papillomavirus.$280,583
N01 · FY2019 · AI · contact PI
Task A21: Human Hepatitis B virus (HBV) mouse models for testing HBV therapeutics$165,448
N01 · FY2019 · AI · contact PI
Task A22: Mouse Model for the Evaluation of Universal Influenza Vaccines and Vaccination Strategies$2,967
N01 · FY2019 · AI · contact PI
Task A11: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES$872,225
N01 · FY2018 · AI · contact PI
TASK A09: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential$584,266
N01 · FY2018 · AI · contact PI
Task A14: Hamster Model for Human Adenovirus$471,140
N01 · FY2018 · AI · contact PI
Task A22: Mouse Model for the Evaluation of Universal Influenza Vaccines and Vaccination Strategies$361,188
N01 · FY2018 · AI · contact PI
Task A13: Rabbit and Mouse Models for Papillomavirus.$280,583
N01 · FY2018 · AI · contact PI
Task A17: Mouse Model of enteroviruses Polio and Coxsackie for Therapeutics$209,061
N01 · FY2018 · AI · contact PI
Task A21: Human Hepatitis B virus (HBV) mouse models for testing HBV therapeutics$174,249
N01 · FY2018 · AI · contact PI
Task A08: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$1,734
N01 · FY2018 · AI · contact PI
TASK A105: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES$813,138
N01 · FY2017 · AI · contact PI
TASK A109: MOUSE MODEL FOR TESTING OF INFLUENZA VACCINE CANDIDATES AND VACCINATION STRATEGIES AGAINST INFLUENZA VIRUS INFECTION$266,000
N01 · FY2017 · AI · contact PI
Task A103: Small animal models for Zika and other flaviviruses$47,538
N01 · FY2017 · AI · contact PI
Task A89: Human Hepatitis B Virus (HBV) Mouse Models for Testing HBV Therapeutics$45,657
N01 · FY2017 · AI · contact PI
Task A103: Small animal models for Zika and other flaviviruses$6,576
N01 · FY2017 · AI · contact PI
Task A99: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential$4,926
N01 · FY2017 · AI · contact PI
Task A90: Small Animal Models for Biodefense Viruses$755,542
N01 · FY2016 · AI · contact PI
Task A10: Small animal models for Zika and other flaviviruses$539,991
N01 · FY2016 · AI · contact PI
Task A99: Mouse Models for Evaluation of Therapeutics against Human Seasonal Influenza and Avian Influenza Strains with Pandemic Potential$479,000
N01 · FY2016 · AI · contact PI
Task A89: Human Hepatitis B Virus (HBV) Mouse Models for Testing HBV Therapeutics$178,461
N01 · FY2016 · AI · contact PI
Collaborative Antiviral Testing Group Annual Meeting$2,456
N01 · FY2016 · AI · contact PI
Task A19 HUMAN HEPATITIS B VIRUS (HBV) MOUSE MODELS FOR TESTING HBV THERAPEUTICS$352,327
N01 · FY2011 · AI · contact PI